Display options
Cite
Riahi S, Mohammadi MT, Sobhani V, et al. Chronic effects of aerobic exercise on gene expression of LOX-1 receptor in the heart of rats fed with high fat diet. Iran J Basic Med Sci. 2015;18(8):805-12
Riahi, S., Mohammadi, M. T., Sobhani, V., & Soleimany, M. (2015). Chronic effects of aerobic exercise on gene expression of LOX-1 receptor in the heart of rats fed with high fat diet. Iranian journal of basic medical sciences, 18(8), 805-12.
Riahi, Simin, et al. "Chronic effects of aerobic exercise on gene expression of LOX-1 receptor in the heart of rats fed with high fat diet." Iranian journal of basic medical sciences vol. 18,8 (2015): 805-12.
Riahi S, Mohammadi MT, Sobhani V, Soleimany M. Chronic effects of aerobic exercise on gene expression of LOX-1 receptor in the heart of rats fed with high fat diet. Iran J Basic Med Sci. 2015 Aug;18(8):805-12. PMID: 26557970; PMCID: PMC4633464.
Copy Download .nbib Format: NLM
Share it on

Iran J Basic Med Sci. 2015 Aug;18(8):805-12.

Chronic effects of aerobic exercise on gene expression of LOX-1 receptor in the heart of rats fed with high fat diet.

Iranian journal of basic medical sciences

Simin Riahi, Mohammad Taghi Mohammadi, Vahid Sobhani, Mansureh Soleimany

Affiliations

  1. Exercise Physiology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  2. Department of Physiology and Biophysics, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  3. Department of Anatomy, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.

PMID: 26557970 PMCID: PMC4633464

Abstract

OBJECTIVES: Lectin-like low density lipoprotein receptor (LOX-1) has pivot role in vascular complications, which is upregulated in numerous pathological conditions. Since exercise has beneficial effects in prevention of hyperlipidemic complications, present study examined protective effects of aerobic exercise through reduction of LOX-1 expression in heart during dyslipidemia.

MATERIALS AND METHODS: Four groups of rats were used (N=25): Normal, Normal and exercise, High fat and High fat and exercise. High fat diet (HFD) was made by adding 10% animal oil, 2% cholesterol and 0.5% colic acid to standard rodent chow. Exercise protocol consisted of swimming 1 hr/day, and 5 days/week for 8 weeks. Plasma lipids were evaluated at the end of experiment, 48 hr after final session of exercise. At the end, rats were sacrificed and heart was removed for determination of malondialdehyde (MDA) content, and LOX-1 expression.

RESULTS: HFD meaningfully changed lipid profile (>50%), but chronic exercise had no significant effects on lipid profile. LOX-1 expression was significantly increased in heart of rats fed with HFD, while swimming exercise considerably reduced gene expression of LOX-1. MDA content was significantly enhanced in rats fed with HFD (4.37±0.6 nmol/mg, P<0.01) compared to normal group (1.56±0.48 nmol/mg), whereas swimming exercise decreased MDA level of heart in rats fed with HFD (2.28±0.32, P<0.01).

CONCLUSION: Findings indicated that swimming exercise is able to diminish heart expression of LOX-1 receptor concomitant reduction of oxidative stress. Since these parameters are involved in generation of dyslipidemic complications, swimming exercise is a good candidate to reduce these complications.

Keywords: Dyslipidemia; LOX-1 receptor; Oxidative stress; Swimming exercise

References

  1. Cardiovasc Drugs Ther. 2011 Oct;25(5):451-9 - PubMed
  2. N Engl J Med. 2002 Nov 7;347(19):1483-92 - PubMed
  3. Eur Heart J. 2014 Oct 21;35(40):2839-48 - PubMed
  4. Public Health Nutr. 1999 Sep;2(3A):369-76 - PubMed
  5. Eur J Appl Physiol. 2014;114(7):1421-8 - PubMed
  6. Thromb Haemost. 2000 Mar;83(3):503-8 - PubMed
  7. Bratisl Lek Listy. 2000;101(10):541-51 - PubMed
  8. Atherosclerosis. 2007 Nov;195(1):48-56 - PubMed
  9. Biochem Biophys Res Commun. 2001 Mar 2;281(3):720-5 - PubMed
  10. Sports Med. 2014 Feb;44(2):211-21 - PubMed
  11. Circulation. 2001 Jun 5;103(22):2705-10 - PubMed
  12. Nutr Metab Cardiovasc Dis. 2012 Feb;22(2):103-8 - PubMed
  13. Cardiovasc Res. 2007 Jun 1;74(3):537-45 - PubMed
  14. Transl Res. 2009 May;153(5):217-23 - PubMed
  15. Circ J. 2007 Jul;71(7):1147-51 - PubMed
  16. Med Sci Sports Exerc. 2004 Mar;36(3):352-62 - PubMed
  17. Clin Biochem. 2014 Sep;47(13-14):1239-44 - PubMed
  18. Indian J Physiol Pharmacol. 2013 Oct-Dec;57(4):378-83 - PubMed
  19. Food Chem Toxicol. 2011 May;49(5):1110-4 - PubMed
  20. Curr Pharm Des. 2009;15(27):3094-107 - PubMed
  21. Metabolism. 2002 Dec;51(12):1587-95 - PubMed
  22. JAMA. 1996 Jul 17;276(3):205-10 - PubMed
  23. J Clin Hypertens (Greenwich). 2006 Dec;8(12 Suppl 4):30-9 - PubMed
  24. J Clin Diagn Res. 2014 Jul;8(7):BC08-10 - PubMed
  25. Prev Cardiol. 2008 Spring;11(2):71-5 - PubMed
  26. Atherosclerosis. 2005 Jan;178(1):33-8 - PubMed
  27. Cardiovasc Res. 1999 Aug 15;43(3):562-71 - PubMed
  28. Clin Sci (Lond). 2011 Aug;121(3):91-106 - PubMed
  29. Am J Physiol. 1999 Apr;276(4 Pt 2):H1346-54 - PubMed
  30. Curr Diab Rep. 2013 Jun;13(3):372-80 - PubMed
  31. Am J Physiol Endocrinol Metab. 2009 Apr;296(4):E775-86 - PubMed
  32. Biochem Biophys Res Commun. 2000 Oct 5;276(3):1100-4 - PubMed
  33. Am J Physiol Renal Physiol. 2008 Jan;294(1):F110-9 - PubMed
  34. J Appl Physiol (1985). 2004 Mar;96(3):1114-26 - PubMed
  35. Circulation. 1999 Jun 22;99(24):3110-7 - PubMed
  36. J Clin Lipidol. 2007 Jul;1(3):175-81 - PubMed
  37. Am J Med. 2010 Oct;123(10):892-8 - PubMed
  38. Cardiovasc Res. 2006 Jan;69(1):36-45 - PubMed
  39. J Cardiopulm Rehabil. 2000 May-Jun;20(3):180-8 - PubMed

Publication Types